Testosterone Science

Media Watch

Menopause and Testosterone

Grade Incomplete reporting Categories: Testosterone in women >> MenopauseMood, cognition and energy

Specific Claim Evaluated

A 2024 pilot study from a UK menopause clinic found that women using transdermal testosterone for 4 months reported significant improvements in mood and cognition.

Primary Research Supporting or Contradicting the Claim

The cited study was a retrospective cohort of 510 women at a single specialist clinic, without a control group, using self-reported symptom scores (Glynne et al., 2024). A meta-analysis of randomized data found no significant effect on cognition (Faulkner et al., 2026), and the consensus statement finds no effect on depressed mood (Davis et al., 2019).

Corrected Evidence-Based Interpretation

Uncontrolled clinic data cannot separate a treatment effect from expectation, regression to the mean or concurrent therapy. Randomized evidence does not show cognitive or mood benefit; the supported indication remains hypoactive sexual desire disorder.

Rationale for Grade

The article acknowledges that testosterone is promoted by social media and that its established benefit is for low sexual desire, which prevents a lower grade. The pilot study is cited as supporting evidence without stating that it was retrospective and uncontrolled. Readers are left without the randomized evidence that contradicts the finding.

References

  1. Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Global consensus position statement on the use of testosterone therapy for women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. PMID
    Supporting excerpt: "The only evidence-based indication for testosterone for women is for HSDD."
  2. Faulkner A, Desai R, Keay N, Ellahi SA, Spector A. Testosterone therapy for cognition in menopause: a systematic review and meta-analysis. Reprod Fertil. 2026;7(4). PMID
    Supporting excerpt: "insufficient to establish an effect rather than as evidence of no effect"
  3. Glynne S, Kamal A, Kamel AM, Reisel D, Newson L. Effect of transdermal testosterone therapy on mood and cognitive symptoms in peri- and postmenopausal women: a pilot study. Arch Womens Ment Health. 2025;28(3):541-550 (published online 2024). PMID
    Supporting excerpt: "A retrospective cohort study undertaken in a UK specialist menopause clinic."

Post a Comment

Shared Decision Making

Bring the Evidence to Your Next Consultation

Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.